These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 33159728)

  • 1. Viscoelastic Tests in the Evaluation of Haemostasis Disturbances in SARS-CoV2 Infection.
    Rodrigues A; Seara Sevivas T; Leal Pereira C; Caiado A; Robalo Nunes A
    Acta Med Port; 2021 Jan; 34(1):44-55. PubMed ID: 33159728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
    D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
    World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Questions about COVID-19 associated coagulopathy: possible answers from the viscoelastic tests.
    Pavoni V; Gianesello L; Pazzi M; Dattolo P; Prisco D
    J Clin Monit Comput; 2022 Feb; 36(1):55-69. PubMed ID: 34264472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronavirus Disease 2019-Associated Coagulopathy.
    Lippi G; Sanchis-Gomar F; Favaloro EJ; Lavie CJ; Henry BM
    Mayo Clin Proc; 2021 Jan; 96(1):203-217. PubMed ID: 33413819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
    Drews RE
    Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study.
    Del Borrello G; Giraudo I; Bondone C; Denina M; Garazzino S; Linari C; Mignone F; Pruccoli G; Scolfaro C; Spadea M; Pollio B; Saracco P
    J Thromb Haemost; 2021 Feb; 19(2):522-530. PubMed ID: 33305475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulopathy in patients with COVID-19: a systematic review and meta-analysis.
    Zhang X; Yang X; Jiao H; Liu X
    Aging (Albany NY); 2020 Nov; 12(24):24535-24551. PubMed ID: 33229625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of COVID-19 Disease on Platelets and Coagulation.
    Wool GD; Miller JL
    Pathobiology; 2021; 88(1):15-27. PubMed ID: 33049751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [COVID-19: Coagulopathy and thrombosis].
    Tazi Mezalek Z
    Rev Med Interne; 2021 Feb; 42(2):93-100. PubMed ID: 33509669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An 89-Year-Old Man with COVID-19-Associated Coagulopathy Presenting with a Prolonged Partial Thromboplastin Time, Lupus Anticoagulant, and a High Titer of Factor VIII Inhibitor.
    Ghafouri S; Rettig M; Kahlon KS
    Am J Case Rep; 2020 Oct; 21():e926728. PubMed ID: 33122620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19: coagulation disorders and anticoagulant treatment in patients hospitalised in ICU.
    Pluta J; Cieniewicz A; Trzebicki J
    Anaesthesiol Intensive Ther; 2021; 53(2):153-161. PubMed ID: 34006056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-associated Coagulopathy Characterization using Rotational Thromboelastometry in a Prospective, Observational Cohort Study: The HemoCoV Study.
    Rodrigues A; Dias Domingues T; Nobre Jesus G; Garção A; Rodrigues AR; Jacinto Correia C; Leal Pereira C; Correia D; Beleza Á; Ribeiro JM
    Acta Med Port; 2023 Jul; 36(7-8):496-505. PubMed ID: 37429589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The most important biomarker associated with coagulation and inflammation among COVID-19 patients.
    Hong LZ; Shou ZX; Zheng DM; Jin X
    Mol Cell Biochem; 2021 Jul; 476(7):2877-2885. PubMed ID: 33742367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-induced coagulopathy: Experience, achievements, prospects.
    Dubey L; Dorosh O; Dubey N; Doan S; Kozishkurt O; Duzenko O; Kozlova O; Ievtukh V; Ladny JR; Pruc M; Szarpak L; Pukach J
    Cardiol J; 2023; 30(3):453-461. PubMed ID: 36588310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peculiarities of blood coagulation disorders in patients with COVID-19].
    Evtugina NG; Sannikova SS; Peshkova AD; Safiullina SI; Andrianova IA; Tarasova GR; Khabirova AI; Rumyantsev AG; Ataullakhanov FI; Litvinov RI
    Ter Arkh; 2021 Nov; 93(11):1255-1263. PubMed ID: 36286646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Overview on Hypercoagulability in COVID-19.
    Singhania N; Bansal S; Nimmatoori DP; Ejaz AA; McCullough PA; Singhania G
    Am J Cardiovasc Drugs; 2020 Oct; 20(5):393-403. PubMed ID: 32748336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19-associated coagulopathy: a concise review on pathogenesis and clinical implications.
    Memar Montazerin S; Najafi H; Shojaei F; Chi G; Goudarzi S; Sharfaei S; Kahe F; Hassanzadeh S
    Infez Med; 2021 Mar; 29(1):1-9. PubMed ID: 33664168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of coagulation status using viscoelastic testing in intensive care patients with coronavirus disease 2019 (COVID-19): An observational point prevalence cohort study.
    Collett LW; Gluck S; Strickland RM; Reddi BJ
    Aust Crit Care; 2021 Mar; 34(2):155-159. PubMed ID: 32773357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major coagulation disorders and parameters in COVID-19 patients.
    Teimury A; Khameneh MT; Khaledi EM
    Eur J Med Res; 2022 Feb; 27(1):25. PubMed ID: 35168674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.